XCTO146: BD Bard Crosser iQ Ultrasonic CTO Device

Sign in to add this product to your favorites!
| Price: | $1,399.00 per box of 1 |
|---|---|
| Quantity: | |
| In Stock: | 4 box of 1 |
| Status: | expired |
Related Items
CRU14SA $42.00 $16.80 per kit Bard Crosser CTO Recanalization Catheter: 14S Peripheral, RX Expired Units in stock: 3 kits | Order Qty |
CRUS6A $6.00 per kit Bard Crosser CTO Recanalization Catheter: S6 Peripheral, 154cm Expired Units in stock: 2 kits | Order Qty |
SCCTO110AT - Size: 0.035" $99.00 $49.50 per kit BD Bard Recon Support Catheter 6F x 110cm, Angled Tapered Expired Units in stock: 5 kits | Order Qty |
SCCTO110 - Size: 0.035" $99.00 $49.50 per kit BD Bard Recon Support Catheter 6F x 110cm, Straight Expired Units in stock: 5 kits | Order Qty |
CRUS6106 $42.00 $8.40 per kit Bard Crosser CTO Recanalization Catheter: S6 Peripheral, 106cm Expired Units in stock: 3 kits | Order Qty |
CRUS106 $42.00 $8.40 per kit Bard Crosser CTO Recanalization Catheter: 14S Peripheral RX, 106cm Expired Units in stock: 2 kits | Order Qty |
CRUO14SA $42.00 $8.40 per kit Bard Crosser CTO Recanalization Catheter: 14S Peripheral, OTW Expired Units in stock: 7 kits | Order Qty |
Additional Details
BD Bard Crosser iQ Ultrasonic CTO Device
The Crosser iQ™ Ultrasonic CTO Device is connected to the BD Recanalization System Console via the power cord, through which power is converted into high-frequency ultrasonic mechanical vibrations to the tip of the device.
- Designed to help cross peripheral arterial CTOs intraluminally
- Automatically and selectively ablates plaque, while remaining atraumatic to elastic tissue
- Simple, "plug-and-play" system
- 5F sheath compatible, over-the-wire
- 0.014" guidewire compatible
- 146 cm working length
AccessGUDID Info
- FDA Product Code: PDU
- FDA Product Code Name: Catheter for crossing total occlusions
- GMDN Term Code: 45188
- GMDN Term Name: Mechanical atherectomy system catheter, coronary/peripheral
- GMDN Term Description: A sterile, flexible tube (catheter) intended to be percutaneously introduced for the intraluminal mechanical disruption of atheroma plaque from the walls of both coronary and peripheral arteries (or vein grafts). It has a power-driven cutting or abrasive head for slicing/grinding the atheroma into fragments small enough to be aspirated or absorbed. This is a single-use device.
Manufacturer
C.R. Bard (a part of BD - Becton, Dickinson and Company) was a global leader in the development and manufacturing of innovative medical technologies. Known for their high-quality products, Bard specialized in solutions for vascular access, urology, oncology, and surgical specialties. Their product portfolio included catheters, biopsy devices, implantable ports, and hernia repair systems, designed to enhance patient care and procedural efficiency. As part of BD, the legacy of C.R. Bard continues to drive advancements in healthcare, delivering trusted solutions that improve outcomes for patients and providers worldwide.
IN-DATE